Discussion forum response to Canepa et al

Carolyn S P Lam^{1

2

3

4}, Adriaan A Voors², Rudolf A de Boer², Scott D Solomon^{5

6}, Dirk J van Veldhuisen²

Affiliations

¹ National Heart Centre Singapore, 5 Hospital Drive, Singapore.
² Department of Cardiology, University Medical Center Groningen, University of Groningen, AB31, Hanzeplein 1, Groningen, the Netherlands.
³ Duke-National University of Singapore Medical School, Singapore.
⁴ Cardiovascular Research Institute, National University Heart Centre, Singapore.
⁵ Harvard Medical School, Harvard University, Boston, MA, USA.
⁶ Division of Cardiovascular Medicine, Brigham and Women's Hospital, 75 Francis St, Boston, MA, USA.

Comment

Carolyn S P Lam et al. Eur Heart J. 2019.

. 2019 Feb 21;40(8):705-706.

doi: 10.1093/eurheartj/ehy796.

Carolyn S P Lam^{1

2

3

4}, Adriaan A Voors², Rudolf A de Boer², Scott D Solomon^{5

6}, Dirk J van Veldhuisen²

¹ National Heart Centre Singapore, 5 Hospital Drive, Singapore.
² Department of Cardiology, University Medical Center Groningen, University of Groningen, AB31, Hanzeplein 1, Groningen, the Netherlands.
³ Duke-National University of Singapore Medical School, Singapore.
⁴ Cardiovascular Research Institute, National University Heart Centre, Singapore.
⁵ Harvard Medical School, Harvard University, Boston, MA, USA.
⁶ Division of Cardiovascular Medicine, Brigham and Women's Hospital, 75 Francis St, Boston, MA, USA.

No abstract available

Comment in

Letter regarding the article 'Heart failure with preserved ejection fraction: from mechanisms to therapies' by Lam and colleagues.
Tini G, Olivotto I, Canepa M. Tini G, et al. Eur Heart J. 2019 Feb 21;40(8):703-704. doi: 10.1093/eurheartj/ehy794. Eur Heart J. 2019. PMID: 30500889 No abstract available.

Heart failure with preserved ejection fraction: from mechanisms to therapies.
Lam CSP, Voors AA, de Boer RA, Solomon SD, van Veldhuisen DJ. Lam CSP, et al. Eur Heart J. 2018 Aug 7;39(30):2780-2792. doi: 10.1093/eurheartj/ehy301. Eur Heart J. 2018. PMID: 29905796 Review.